trial · primary record
SAD IV Dose 1 - 150mg ABS201 IV Single Dose
Androgenetic Alopecia (AGA)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 227 |
| Primary completion | 2028-07 |
| Primary endpoint | Incidence rate of treatment-emergent adverse events (TEAEs) and serious TEAEs |
| Registry ID | NCT07317544 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:34.017Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07317544
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.